A laboratory technician supervises capped vials during filling and packaging tests for the large-scale production and supply of the University of Oxfords COVID-19 vaccine candidate, AZD1222, conducted on a high-performance aseptic vial filling line on September 11, 2020 at the Italian biologics manufacturing facility of multinational corporation Catalent in Anagni, Italy. Vincenzo Pinto/AFP/Getty Images
The Oxford University coronavirus vaccine trials will resume after being halted Sunday after an unexplained illness in one of its volunteers, the university said in a statement today.
The university, which is working with drug giant AstraZeneca, did not say what day the trial would resume.
“Globally some 18,000 individuals have received study vaccines as part of the trial. In large trials such as this, it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety,” the statement said.
